PD-166866 100 mg | 99.98%
TargetMol
PD-166866
Search Results
(RS)-MCPG 5 mg | Purity Not Available
TargetMol
(RS)-MCPG is a non-selective group I/II metabotropic glutamate receptor antagonist.
More Information Supplier Page(RS)-MCPG
(RS)-MCPG 50 mg | Purity Not Available
TargetMol
(RS)-MCPG is a non-selective group I/II metabotropic glutamate receptor antagonist.
More Information Supplier Page(RS)-MCPG
NU2058 5 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
NU2058 50 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
NU2058 25 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
NU2058 10 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
NU2058 100 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
Metadoxine 100 mg | Purity Not Available
TargetMol
Metadoxine
Metadoxine 50 mg | Purity Not Available
TargetMol
Metadoxine